Synapse - Genitourinary Oncology Service

Results (5696)

Impact of cisplatin-related adverse health outcomes (AHOs) on employment outcomes and self-reported health (SRH) among testicular cancer survivors (TCS)

Meeting Abstract

Kerns, S. L.; Fung, C.; Fossa, S. D.; Dinh, P. C.; Monahan, P. O.; Sesso, H. D.; Frisina, R. D.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Comparative genomic profiling from tumor tissue and circulating tumor DNA (ctDNA) in 111 patients (Pts) with metastatic clear cell renal cell carcinoma

Meeting Abstract

Kotecha, R.; Gedvilaite, E.; Murray, S. J.; Motzer, R. J.; Tsui, D.; Voss, M. H.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S. B.; Chou, J. F.; Gabler, A.; Simmons, M.; Momtaz, P.; Sanchez-Vega, F.; Shcherba, M.; Ku, G. Y.; Won, E.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer

Meeting Abstract

Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Melhem-Bertrandt, A.; Flaig, T. W.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

PSA decline and objective response rates in White (W), Black (B), and Asian men with metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Halabi, S.; Dutta, S.; Chi, K. N.; Tangen, C. M.; Xuan, M.; Petrylak, D. P.; Araujo, J. C.; Fizazi, K.; Quinn, D. I.; Morris, M. J.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents

Meeting Abstract

Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)

Meeting Abstract

Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A pilot safety study of gemcitabine and cisplatin (GC) with atezolizumab (A) as first-line therapy in patients (pts) with metastatic urothelial cancer (mUC)

Meeting Abstract

Funt, S. A.; Jatwani, K.; Makris, M.; Regazzi, A. M.; Lee, C. H.; Teo, M. Y.; McHugh, D. J.; McCoy, A. S.; Hettich, G.; Wong, P.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Biomarkers of outcomes in a randomized phase II trial of first-line paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for intermediate- and poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J. S.; Patil, S.; Reuter, V. E.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Milowsky, M. I.; Appleman, L. J.; Dorff, T. B.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)

Meeting Abstract

Eastham, J. A.; Heller, G.; Halabi, S.; Monk, P.; Clinton, S. K.; Szmulewitz, R. Z.; Coleman, J.; Gleave, M.; Evans, C. P.; Hillman, D. W.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save